| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2002 | US6420546 Oligoribonucleotide and ribozyme analogs with terminal 3′—3′ and/or 5′—5′ linkages |
| 07/16/2002 | US6420545 Nucleotide sequences coding polypeptide for use in the treatment of preferential viral diseases |
| 07/16/2002 | US6420538 Aromatic amides, preparation method and application as medicines |
| 07/16/2002 | US6420537 Generating azithromycins; obtain preferential erythromycin derivative, methylate in the presence of formaldehyde and reducing agent, recover azithromycins |
| 07/16/2002 | US6420536 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 07/16/2002 | US6420532 Binding to human y2 receptors and expression |
| 07/16/2002 | US6420468 Pre-polymerization, monomer(s) dissolved in water-miscible aprotic organic solvent forming non-solvent mixture of polymer; prophylactic or curative antibiotics or antiseptic agents |
| 07/16/2002 | US6420435 Method for treating gastrointestinal disorders |
| 07/16/2002 | US6420434 Inorganic polymers comprised of potassium, phosphoric, tungstic, titanic, vanadic, and molybdic acids in polytetra-fluoroethylene / perfluorinated polyether resin; neutralizes vx, soman, and mustard gas; nonirritating |
| 07/16/2002 | US6420433 S(+) desmethylselegiline and drug withdrawal |
| 07/16/2002 | US6420432 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |
| 07/16/2002 | US6420430 Use of benzoylguanidine derivatives to prevent aging disorders |
| 07/16/2002 | US6420429 Brain targeted low molecular weight hydrophobic antioxidant compounds |
| 07/16/2002 | US6420428 Treatment and prevention of hepatic disorders |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420426 Used to treat complications from diabetes mellitus |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420422 Ocular hypotensive agents |
| 07/16/2002 | US6420421 Alkyl-dimethyl-benzyl or ethylbenzyl ammonium chloride mixture and bis(tri-n-butyltin)oxide; used to treat viral, bacterial and fungal infections in mammals and avians |
| 07/16/2002 | US6420420 Method for increasing the concentration of ascorbic acid in brain tissue of a subject |
| 07/16/2002 | US6420419 L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same |
| 07/16/2002 | US6420418 Inhibition and prevention of leukocyte adhesion; used to treat adhesion-mediated diseases such as asthma, allergic rhinitis, multiple sclerosis; atherosclerosis, and inflammatory bowel disease |
| 07/16/2002 | US6420417 Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| 07/16/2002 | US6420416 Administering nefiracetam |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds |
| 07/16/2002 | US6420412 Eprosartan dihydate and a process for its production and formulation |
| 07/16/2002 | US6420411 Compounds and methods for use thereof in the treatment of cancer or viral infections |
| 07/16/2002 | US6420410 Administering n,n'-substituted benzimidazol-2-ones to induce apoptosis in neoplastic cells but not normal cells; anticancer, antitumor agent |
| 07/16/2002 | US6420409 Benzimidazole derivatives |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420407 Ophthalmic formulation which modulates dilation |
| 07/16/2002 | US6420405 Pharmaceutical composition for angiotensin II-mediated diseases |
| 07/16/2002 | US6420404 D-cycloserine (d-4-amino-3-isooxazolidinone) and prodrugs; glycine b partial agonists; cognition activators; alzheimer's disease |
| 07/16/2002 | US6420402 Blocking of associated non-inactivating sodium channels in retinal ganglion cells in order to limit sodium/calcium exchange in retinal ganglion cells and prevent buildup of calcium level in retinal ganglion cells to a lethal level |
| 07/16/2002 | US6420399 Topical ophthalmic mast cell stabilizers for treating allergic eye disease |
| 07/16/2002 | US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse. |
| 07/16/2002 | US6420394 Topically applied pharmaceutical formulation |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420390 Heteroarylpiperidines and their use as antipsychotics |
| 07/16/2002 | US6420388 Osanetant in the treatment of depression and depressive disorders |
| 07/16/2002 | US6420387 Antitumor |
| 07/16/2002 | US6420386 Spinal traumatism, epilepsy, chronic neurodegenerative diseases such as alzheimer's disease, schizophrenia, lateral amyotrophic sclerosis or huntington's chorea. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420383 Calcium channel blockers, hypersensitivity, allergy, asthma, bronchospasm, dysmenorrhea, esophageal spasm, glaucoma, premature labor, urinary tract disorders, gastrointestinal motility disorders and cardiovascular disorders. |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420380 Hepatitis C inhibitor tri-peptides |
| 07/16/2002 | US6420379 Alkynyl-substituted camptothecins and process for their preparation |
| 07/16/2002 | US6420378 Synergistic effects of 9-nitro-20(s)-camptothecin and an antibody, antitumor |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420374 Pentoxifylline. |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420372 Tropical malarial antiprotozoan |
| 07/16/2002 | US6420371 Angiogenesis inhibitor |
| 07/16/2002 | US6420369 Anticonvulsant derivatives useful in treating dementia |
| 07/16/2002 | US6420368 Thienopyrimidines |
| 07/16/2002 | US6420366 1-(4-arylpiperazin-1-yl)-ω-[N-(αω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420364 Treating autoimmune diseases,alzheimer's disease, atherosclerosis, osteoporosis, |
| 07/16/2002 | US6420360 Sultam and sultone derived oxazolidinones |
| 07/16/2002 | US6420359 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl)oxy)ethyl)-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one for example; antiviral agents for HIV infection |
| 07/16/2002 | US6420358 Increasing urine flow in a human while inhibiting loss of electrolytes or ions, edema, hypertension |
| 07/16/2002 | US6420353 Use of 7 α-substituted steroid to treat neuropsychiatric, immune or endocrine disorders |
| 07/16/2002 | US6420351 Administering mixture of alanine, serine, methylglycine and cycloserine |
| 07/16/2002 | US6420350 Weight loss product |
| 07/16/2002 | US6420348 Pectic polysaccharides purified from Angelica gigas nakai and purification method and use as immunostimulating agent thereof |
| 07/16/2002 | US6420347 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals |
| 07/16/2002 | US6420338 Hepatitis b virus (hbv); hepatocellular carcinoma |
| 07/16/2002 | US6420330 Active against pseudomonas aeruginosa; biodegradabile; detergents, disinfectants, preservatives, fabric softeners, cosmetics, cooling lubricant emulsions and coatings |
| 07/16/2002 | US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor |
| 07/16/2002 | US6420176 Composition for delivering DNA into antigen presenting cells |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420160 Expression vector for use in immunotherapy and gene therapy |
| 07/16/2002 | US6420155 Polypeptide for use in the treatment of cancer and atherosclerosis |
| 07/16/2002 | US6420134 Vaccines for nontypable haemophilus influenzae |
| 07/16/2002 | US6420127 Prevention of microorganismal infections; obtain membranes, incubate with modulators, monitor microorganismal infections |
| 07/16/2002 | US6420126 Tumor specific internalizing antigens and methods for targeting therapeutic agents |
| 07/16/2002 | US6420121 Prevention of cell migration initiation with CMV US28 receptor antagonists |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6419963 Composition and method for the treatment of diaper rash using natural products |
| 07/16/2002 | US6419960 Oral administering; attention deficit disorder; bead with enteric coating |
| 07/16/2002 | US6419959 Oral administering; side effect reduction |
| 07/16/2002 | US6419958 Extended release formulation of venlafaxine hydrochloride |
| 07/16/2002 | US6419957 Crosslinked with monochloroacetic acid or chloroethylamine hydrochloride |
| 07/16/2002 | US6419955 Process for making bisphosphonate compositions |
| 07/16/2002 | US6419954 Mixture containing gelled polymer |
| 07/16/2002 | US6419953 Controlled release formulation of divalproex sodium |
| 07/16/2002 | US6419950 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same |
| 07/16/2002 | US6419948 Treating nervous system disorders such as attention deficit hyperactivity disorder, or immune system dysfunction due to aids, cancer chemotherapy, infections |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | US6419914 Polymer with pendant acid functional groups; will not degrade in the gastrointestinal tract |
| 07/16/2002 | US6419913 Topical delivery systems for active agents |
| 07/16/2002 | US6419901 Anticancer agents |
| 07/16/2002 | US6419900 Formulation and method for treating neoplasms by inhalation |
| 07/16/2002 | US6419899 Administering drugs |
| 07/16/2002 | US6419850 System and composition for decontaminating fluids |
| 07/16/2002 | US6419677 Spine distraction implant and method |